Wide Ranks

CAMP

CAMP4 THERAPEUTICS CORPORATION

4.69

Top Statistics
Market Cap 94 M Forward PE -1.64 Revenue Growth 0.00 %
Current Ratio 1.90 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -3.28 Enterprise / Revenue 465.42 Price To Sales Trailing12 Months 270.16
Profitability
Profit Margins 0.00 % Operating Margins -14671.43 %
Balance Sheet
Total Cash 12 M Total Cash Per Share 25.68 Total Debt 10 M
Total Debt To Equity 69.97 Current Ratio 1.90 Book Value Per Share -268.57
All Measures
Short Ratio 272.00 % Message Board Id finmb_569025678 City Cambridge
Uuid b3c26f55-b1d5-368c-93b3-b92b8939d995 Previous Close 4.94 First Trade Date Epoch Utc 1 B
Book Value -268.57 Total Debt 10 M Volume 48701
Fifty Two Week Low 4.06 Total Cash Per Share 25.68 Total Revenue 350000
Target Median Price 20.32 Max Age 86400 Recommendation Mean 1.50
Sand P52 Week Change 0.3133 Operating Margins -14671.43 % Target Mean Price 20.16
Net Income To Common -49713000 Short Percent Of Float 0.0251 Implied Shares Outstanding 20 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 72770
Average Volume10days 72770 Total Cash 12 M Next Fiscal Year End 1 B
Revenue Per Share 0.7860 Held Percent Insiders 0.3659 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 4.94
Target Low Price 17.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 9.26
Open 5.02 Dividend Yield 0.00 % State MA
Time Zone Short Name EST Trailing Eps -2.64 Day Low 4.51
Address1 One Kendall Square Shares Outstanding 20 M Price Hint 4
Target High Price 23.00 Website https://www.camp4tx.com 52 Week Change -0.5625
Average Volume 102435 Forward Eps -3.01 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 166.40 % Is_sp_500 False
Regular Market Day High 5.04 Profit Margins 0.00 % Debt To Equity 69.97
Fifty Two Week High 12.30 Day High 5.04 Shares Short 256614
Regular Market Open 5.02 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue 465.42 Revenue Growth 0.00 % Shares Percent Shares Out 0.0194
Operating Cashflow -42918000 Currency USD Time Zone Full Name America/New_York
Market Cap 94 M Is_nasdaq_100 False Zip 02139
Quote Type EQUITY Industry Biotechnology Regular Market Day Low 4.51
Held Percent Institutions 0.4204 Current Price 4.69 Address2 Building 1400 West 3rd Floor
Enterprise To Ebitda -3.28 Financial Currency USD Current Ratio 1.90
Industry Disp Biotechnology Number Of Analyst Opinions 4 Country United States
Float Shares 82035 Two Hundred Day Average 9.26 Enterprise Value 162 M
Price To Sales Trailing12 Months 270.16 Forward PE -1.64 Regular Market Volume 48701
Ebitda -49625000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.

Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders.

The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders.

Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018.

The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.